We are live on ! Find out more
RAIN

Rain Oncology Inc. Common Stock
RAIN

Delisted

RAIN was delisted on the 25th of January, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Rain Oncology Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 58 → 0 (-58)

100% less capital invested

Capital invested by funds: $20.4M → $0 (-$20.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 58

Holders
–
Holders Change
-58
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$4.62M
2
BI
BVF Inc
California
-$4.23M
3
SB
Samsara BioCapital
California
-$2.44M
4
BCM
BML Capital Management
Indiana
-$1.62M
5
BC
Boxer Capital
California
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
PenderFund Capital Management
British Columbia, Canada
– -$61.5K -38,650 Closed
AFM
27
Anson Funds Management
Texas
– -$40.3K -33,568 Closed
VF
28
Virtu Financial
New York
– -$40K -33,344 Closed
Fidelity Investments
29
Fidelity Investments
Massachusetts
– -$38.5K -32,054 Closed
UBS Group
30
UBS Group
Switzerland
– -$35.1K -29,291 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$34.2K -28,491 Closed
Russell Investments Group
32
Russell Investments Group
United Kingdom
– -$30K -25,010 Closed
Barclays
33
Barclays
United Kingdom
– -$28.8K -24,013 Closed
HKAM
34
Horizon Kinetics Asset Management
New York
– -$28.8K -23,992 Closed
Osaic Holdings
35
Osaic Holdings
Arizona
– -$28.6K -23,838 Closed
Neuberger Berman Group
36
Neuberger Berman Group
New York
– -$26.1K -21,742 Closed
SC
37
Shay Capital
New York
– -$25.9K -21,598 Closed
Bank of America
38
Bank of America
North Carolina
– -$23.1K -19,224 Closed
JP Morgan Chase
39
JP Morgan Chase
New York
– -$20.7K -17,220 Closed
N
40
Nuveen
North Carolina
– -$20.1K -16,731 Closed
SEI Investments
41
SEI Investments
Pennsylvania
– -$20.1K -16,731 Closed
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
– -$19.2K -16,007 Closed
Renaissance Technologies
43
Renaissance Technologies
New York
– -$13K -11,100 Closed
AIG
44
American International Group
New York
– -$10.5K -8,784 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$9.98K -8,316 Closed
Wells Fargo
46
Wells Fargo
California
– -$6.29K -5,245 Closed
ASN
47
Advisory Services Network
Georgia
– -$5.09K -4,239 Closed
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
– -$5K -3,770 Closed
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
– -$3.49K -2,909 Closed
Citigroup
50
Citigroup
New York
– -$3.1K -2,584 Closed
1
2
3

RAIN Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q1 2024, worth a combined $0 — down 100% from $20.4M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of RAIN and 0 opened new positions — a net loss of 58 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $4.62M sold.

  • 0 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q1 2024, down from 58 in Q4 2023.
  • Funds reported $0 of Rain Oncology Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Rain Oncology Inc. Common Stock positions in Q1 2024 and 58 closed out, a net change of -58 holders.
  • The largest Rain Oncology Inc. Common Stock seller in Q1 2024 was Tang Capital Management, an estimated $4.62M sold.

Based on aggregated 13F filings for Q1 2024.